Editas Medicine Inc (EDIT) — Cash Flow-to-Debt Ratio
Editas Medicine Inc (EDIT) has a Cash Flow-to-Debt Ratio of -0.16x as of March 2026, meaning its operating cash flow of $-23.06 Million could theoretically repay 0% of its total liabilities ($144.93 Million) in one year. See how much free cash does Editas Medicine Inc generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Editas Medicine Inc Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Editas Medicine Inc across 13 annual periods. Also explore Editas Medicine Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Editas Medicine Inc (2013–2025)
Year-by-year debt coverage analysis for Editas Medicine Inc. For market capitalisation and broader financial context, see Editas Medicine Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.04x | $-165.24 Million | $159.25 Million | ▼ -2.3% |
| 2024 | -1.01x | $-210.28 Million | $207.31 Million | ▼ -15.2% |
| 2023 | -0.88x | $-132.18 Million | $150.06 Million | ▲ +23.7% |
| 2022 | -1.15x | $-177.35 Million | $153.64 Million | ▲ +12.7% |
| 2021 | -1.32x | $-163.80 Million | $123.84 Million | ▼ -31.7% |
| 2020 | -1.00x | $-179.84 Million | $179.02 Million | ▼ -508.8% |
| 2019 | -0.17x | $-40.67 Million | $246.45 Million | ▲ +33.5% |
| 2018 | -0.25x | $-45.71 Million | $184.22 Million | ▼ -335.2% |
| 2017 | -0.06x | $-9.42 Million | $165.18 Million | ▲ +89.2% |
| 2016 | -0.53x | $-49.93 Million | $94.58 Million | ▼ -2171.4% |
| 2015 | -0.02x | $-5.40 Million | $232.48 Million | ▲ +92.6% |
| 2014 | -0.31x | $-8.65 Million | $27.48 Million | ▲ +52.0% |
| 2013 | -0.66x | $-2.78 Million | $4.24 Million | — |